Papillary Renal Cell Carcinomas Rewire Glutathione Metabolism and Are Deficient in Both Anabolic Glucose Synthesis and Oxidative Phosphorylation
Papillary renal cell carcinoma (pRCC) is a malignant kidney cancer with a prevalence of 7−20% of all renal tumors. Proteome and metabolome profiles of 19 pRCC and patient-matched healthy kidney controls were used to elucidate the regulation of metabolic pathways and the underlying molecula...
Main Authors: | Ayham Al Ahmad, Vanessa Paffrath, Rosanna Clima, Jonas Felix Busch, Anja Rabien, Ergin Kilic, Sonia Villegas, Bernd Timmermann, Marcella Attimonelli, Klaus Jung, David Meierhofer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/9/1298 |
Similar Items
-
Cultivation of Clear Cell Renal Cell Carcinoma Patient-Derived Organoids in an Air-Liquid Interface System as a Tool for Studying Individualized Therapy
by: Laura K. Esser, et al.
Published: (2020-09-01) -
A pan-kidney cancer study identifies subtype specific perturbations on pathways with potential drivers in renal cell carcinoma
by: Xiaohui Zhan, et al.
Published: (2020-12-01) -
Differential Expression of the Androgen Receptor, Splice Variants and Relaxin 2 in Renal Cancer
by: Joanna Bialek, et al.
Published: (2021-07-01) -
Role of the KEAP1-NRF2 Axis in Renal Cell Carcinoma
by: Sara Clerici, et al.
Published: (2020-11-01) -
Glutathione Metabolism in Renal Cell Carcinoma Progression and Implications for Therapies
by: Yi Xiao, et al.
Published: (2019-07-01)